SCHEMBL6504800

SCHEMBL6504800

COc1ccc(Br)cc1C=CC(=O)N1CCC(C(=O)NC(C)C(=O)O)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.51
KDM4E B2RXH2 3/20 0.46
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 2/20 0.43
TNFRSF1A P19438 1/20 0.43
HPGD P15428 1/20 0.43
CAPN1 P07384 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
ITGAL P20701 2/20 0.42
MITF O75030 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504799 1.00 SMN1; SMN2 (0.51) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6505741 0.87 NPC1 (0.44) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6500476 0.87 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL6500473 0.87 SMN1; SMN2 (0.66) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL6505746 0.87 NPC1 (0.44) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6502814 0.85 NPC1 (0.46) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6496329 0.85 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AMEN1KMT2A
SCHEMBL6496828 0.85 KDM4E (0.48) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6496819 0.85 KDM4E (0.48) SMN1; SMN2KDM4EMAPTALDH1A1NPC1
SCHEMBL6496331 0.85 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed